Newer basal insulin analogues: degludec, detemir, glargine
Kalra, S.
Jpma. Journal of the Pakistan Medical Association 63(11): 1442-1444
2013
ISSN/ISBN: 0030-9982 PMID: 24392539 Document Number: 671222
Document emailed within 1 workday
Related Documents
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89Agarwal, S.K.; Singh, B.K.; Wadhwa, R. 2013: Study of optimal basal insulin glargine dose requirement in Indian population as an add on therapy to oral hypoglycaemic agents to achieve target fasting blood glucose levels Journal of the Indian Medical Association 111(9): 626-628
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
John, M. 2011: Basal insulin analogues--a review of recent data on efficacy and safety Journal of the Association of Physicians of India 59 Suppl: 25-28
Mohan, V.; Das, A.K.; Joshi, S.R. 2015: Insulin Degludec/Insulin Aspart: a Novel Co-formulation for Insulin Intensification Journal of the Association of Physicians of India 63(5 Suppl): 6-7
Bantwal, G.; Wangnoo, S.K.; Shunmugavelu, M.; Nallaperumal, S.; Harsha, K.P.; Bhattacharyya, A. 2015: Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes Management Journal of the Association of Physicians of India 63(5 Suppl): 21-28
Ratner, R. 2003: Insulin glargine versus NPH insulin in patients with type 1 diabetes Drugs of Today 39(11): 867-876
King, A. 2012: Advances in insulin therapy: a review of insulin degludec Journal of Family Practice 61(5 Suppl): S28-S31
Chatterjee, S.; Majumder, A.; Goyal, G. 2013: Discovery of insulin--from isletin to degludec and beyond Journal of the Indian Medical Association 111(11): 729
Barlocco, D. 2003: Insulin detemir. Novo Nordisk Current Opinion in Investigational Drugs 4(4): 449-454
Rausch, R. 2014: Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec Medizinische Monatsschrift für Pharmazeuten 37(7): 273-274
2010: Cancer risk in diabetic patients treated with insulin glargine? Prescrire International 19(108): 162-163
Pan, C.-y.; Ji, L.-n.; Lu, J.-m.; Yang, W.-y.; Zhou, Z.-g.; Zou, D.-j.; Ji, Q.-h.; Han, P.; Liu, J.; Li, Q.; Su, B.-l.; Li, Y.-b.; Gao, Z.-n.; Wang, P.-h.; Yin, S.-n.; Dong, Y.-h.; Yang, T.; Sun, K.; Li, H.; Hong, X.; Lin, J.; Shi, J.-m.; Yang, X.-J.; Fang, H.; Yan, X.-d. 2012: The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study Zhonghua Nei Ke Za Zhi 51(12): 957-961
Liebl, A.; Wilhelm, B.; Kaiser, M. 2012: Once daily insulin detemir in patients with type 2 diabetes: results of German centers in a 6-month international observational study (SOLVE) MMW Fortschritte der Medizin 154 Suppl. 4: 102-109
Pan, C.; Ji, L.; Lu, J.; Yang, W.; Zhou, Z. 2015: Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study Zhonghua Nei Ke Za Zhi 54(7): 612-617
Dobrohorska, H.; Sulima, D.; Oskaldowicz, K.; Gruszczyńska, M.; Gołebiowska, I. 1981: Effect of refeeding after starvation on basal and tolbutamide-stimulated insulin secretion and beta-adrenergic receptor function in the regulation of insulin release and lipolysis in obese patients Acta Physiologica Polonica 32(6): 703-712
Edes, I.; Kranias, E.G. 1990: The effect of phorbol esters and diacylglycerol analogues on the basal phosphoinositide turnover in isolated guinea pig hearts Cardioscience 1(4): 265-274
Bu, S.; Guo, X.-H.; Yang, W.-Y.; Lu, G.-Z.; Yang, Z.-J.; Ren, T.-T.; Gao, Y. 2007: Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen Zhonghua Yi Xue Za Zhi 87(44): 3115-3118
Thompson, C. 1998: Insulin analogues--patient preference may drive prescribing Irish Medical Journal 91(1): 16-17
Adamíková, A.; Rybka, J. 2014: Long-term acting insulin analogues and the risks of hypoglycemic incidence Vnitrni Lekarstvi 60(9): 680-683